Preclinical Models Core

总结 圣地亚哥消化疾病研究中心的临床前模型核心将提供访问 用于临床前研究的胃肠道和肝脏疾病的动物模型，并将有助于表征 以全面和统一的方式前瞻性和回顾性地评估疾病活动。核心 由过去由NIDDK资助的（R24）迷你中心提供的核心服务所产生。 加州，圣地亚哥（UCSD）。创建临床前模型核心的方法基于信息 从中心成员需求的调查，在加州大学圣地亚哥分校以前的迷你中心的经验，广泛的专业知识， 中心成员在消化系统疾病的研究，以及几个中心成员的见解， 担任其他Silvio O的顾问或领导角色。康特中心。核心将提供资源， 兽医科学和技术基础设施，使动物进行全面研究。的 服务内容包括消化系统疾病动物模型的选择和解释咨询， 生前成像和死后检查，包括评分的制定和解释 系统由受过比较病理学训练的兽医完成。因此，核心将真正是“临床前”，因为它将 使用仪器对疾病进行建模和评估，也可用于患者， 在这些模型中可能的可控操作。核心将由两名经验丰富的领导人领导 在将动物模型应用于基础和临床前问题方面有着良好的记录：Peter Ernst博士，博士 一名在管理核心设施方面具有丰富经验的兽医，将担任核心总监，并专注于 胃肠道疾病的鼠模型和体内成像。作为核心联合主任，Tatiana Kisseleva博士 将为她提供肝病动物模型的丰富经验。此外，核心将与 与人类翻译和微生物组学和功能基因组学核心直接互补， 能够将成像结果、生物标志物和临床数据与动物模型中的特定结果相关联 人类疾病。因此，临床前模型核心将通过提供 与研究者的研究和其他核心协调的可靠、具有成本效益的服务， 促进和推进与胃肠道和肝脏相关的研究。

Summary The Preclinical Models Core in the San Diego Digestive Diseases Research Center will provide access to animal models of gastrointestinal and liver disease for preclinical studies and will assist in characterizing disease activity prospectively and retrospectively in a comprehensive and uniform manner. The Core emanated out of core services provided by a past NIDDK-funded (R24) Mini-Center at the University of California, San Diego (UCSD). The approach to create the Preclinical Models Core is based on information from surveys of Center member needs, experience with the prior Mini-Center at UCSD, the broad expertise of Center members in digestive diseases research, and the insights of several of the Center members who have served as advisors or in leadership roles for other Silvio O. Conte Centers. The Core will provide resources in veterinary sciences and a technical infrastructure that enables animals to be studied comprehensively. The services will include consultation on the selection and interpretation of animal models of digestive diseases, ante-mortem imaging and post-mortem examination, including the development and interpretation of scoring systems by veterinarians trained in comparative pathology. Thus, the Core will truly be “preclinical” in that it will be modeling and evaluating disease with instrumentation also used in patients with the added advantage of the controlled manipulations that are possible in these models. The Core will be led by two experienced leaders with strong track records in applying animal models to basic and preclinical questions: Dr. Peter Ernst, a PhD veterinarian with extensive experience in managing Core facilities, will be the Core Director and focus on murine models of gastrointestinal disease and in vivo imaging. As the Core Co-Director, Dr. Tatiana Kisseleva will provide her extensive experience with animal models of liver disease. Furthermore, the Core will interact with and directly complement the Human Translational and Microbiomics and Functional Genomics Cores by being able to relate the imaging results, biomarkers and clinical data to specific outcomes in animal models and human disease. Thus, the Preclinical Models Core will benefit the investigators in the Center by providing reliable, cost-effective services that are coordinated with the investigators’ research and other Cores to facilitate and advance research related to the gastrointestinal tract and liver.